Side-by-side comparison of AI visibility scores, market position, and capabilities
Las Vegas Sands Asia integrated resorts (NYSE: LVS) $11.4B FY2024 revenue; Sands China Macau $8.2B, Marina Bay Sands Singapore $2.93B (+14%), Londoner Macao renovation, competing with Galaxy and Melco.
Las Vegas Sands Corp. is a Las Vegas, Nevada-based integrated resort developer and operator — publicly traded on the New York Stock Exchange (NYSE: LVS) as an S&P 500 Consumer Discretionary component — developing, owning, and operating luxury integrated resort destinations in Macau, China (through Sands China Ltd., 69.4% owned subsidiary listed on Hong Kong Stock Exchange) and Singapore (Marina Bay Sands) through approximately 40,000 employees, following the 2021 sale of its Las Vegas properties (The Venetian, Palazzo, Las Vegas Sands Expo Center) to Apollo Global Management for $6.25 billion. In fiscal year 2024, Las Vegas Sands reported revenues of $11.4 billion (+5.7% year-over-year), with Macao Operations generating $8.2 billion ($4.49B at The Venetian Macao, $2.0B at Sands Macao, Four Seasons Macao, Parisian Macao, and Londoner Macao) and Singapore's Marina Bay Sands generating $2.93 billion (+14.3%). CEO Robert Goldstein leads Las Vegas Sands' strategy of Macau portfolio renovation and Singapore expansion: the Londoner Macao renovation ($2 billion+ investment transforming the former Sands Cotai Central into the Londoner Macao resort) completed its final tower renovations in 2024, while the Marina Bay Sands Tower 3 expansion (adding 1,000 hotel rooms, additional gaming floors, and a new arena for concerts and events) received Singapore government approval targeting 2028 completion.
San Jose clear aligner orthodontics inventor (NASDAQ: ALGN) at $3.23B 2024 revenue; 20 million Invisalign patient milestone Q1 2025 across 280,000+ doctors with iTero Lumina scanner competing with 3M Clarity for orthodontic clear aligner prescriptions.
Align Technology, Inc. is a San Jose, California-based global medical device company — publicly traded on NASDAQ (NASDAQ: ALGN) as an S&P 500 component — operating as the inventor of the Invisalign System and the world leader in clear aligner orthodontics, reaching 20 million Invisalign patients treated worldwide in Q1 2025 through a network of 280,000+ Invisalign-trained doctors across 100+ countries. In fiscal year 2024, Align reported $3.23 billion in total revenue with Q4 2024 revenue of $995.2 million (+4.0% year-over-year). Align's product portfolio comprises the Invisalign System of clear aligners, iTero intraoral digital scanners (including the iTero Lumina with 3X wider field of capture in a 50% smaller wand), and exocad CAD/CAM software for digital dental workflows. Manufacturing is based in Mexico with treatment planning performed in Costa Rica. CEO Joseph Hogan joined from GE Healthcare in 2015. Founded 1997 by Zia Chishti and Kelsey Wirth in San Jose.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.